Requirement for YAP1 signaling in myxoid liposarcoma

Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019)
In: EMBO Molecular Medicine, 2019
Type of Publication: Research article (journal)

Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma

Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019)
In: Molecular Cancer Therapeutics, 2019
Type of Publication: Research article (journal)

PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation

Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017)
In: Bone Marrow Transplantation, 52(2)
Type of Publication: Research article (journal)

Control of multidrug-resistant pseudomonas aeruginosa in allogeneic hematopoietic stem cell transplant recipients by a novel bundle including remodeling of sanitary and water…

Kossow A., Kampmeier S., Willems S., Berdel W., Groll A., Burckhardt B., Rossig C., Groth C., Idelevich E., Kipp F., Mellmann A., Stelljes M. (2017)
In: Clinical Infectious Diseases, 65(6)
Type of Publication: Research article (journal)

Adoptive Therapy of Ewing Sarcoma with GD2 Antigen-Specific Car-Engineered NK Cells Induces Upregulation of Immune-Inhibitory HLA-G

Rossig C, Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Wiek C, Hanenberg H, Hartmann W, Wiendl H, Meltzer J, Farwick N, Greune L (2016)
In: Pediatric Blood and Cancer, 63(3)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

Requirement for YAP1 signaling in myxoid liposarcoma Trautmann M, Cheng Y, Jensen P, Azoitei N, Brunner I, Hüllein J, Slabicki M, Isfort I, Cyra M, Berthold R, Wardelmann E, Huss S, Altvater B, Rossig C, Hafner S, Simmet T, Ståhlberg A, Åman P, Zenz T, Lange U, Kindler T, Scholl C, Hartmann W, Fröhling S (2019) In: EMBO Molecular Medicine, 2019 Type of Publication: Research article (journal)
SS18-SSX-dependent YAP/TAZ Signaling in Synovial Sarcoma Isfort I, Cyra M, Elges S, Kailayangiri S, Altvater B, Rossig C, Steinestel K, Grünewald I, Huss S, Eßeling E (2019) In: Clinical Cancer Research, 2019 Type of Publication: Research article (journal)
Phosphatidylinositol-3-kinase (PI3K)/Akt signaling is functionally essential in myxoid liposarcoma Trautmann M, Cyra M, Isfort I, Jeiler B, Krüger A, Grünewald I, Steinestel K, Altvater B, Rossig C, Hafner S (2019) In: Molecular Cancer Therapeutics, 2019 Type of Publication: Research article (journal)
Cytomegalovirus retinitis in children and adolescents with acute leukemia following allogeneic hematopoietic stem cell transplantation Zöllner SK, Herbrüggen H, Kolve H, Mihailovic N, Schubert F, Reicherts C, Rössig C, Groll AH (2019) In: Transplant Infectious Disease, 21(5) Type of Publication: Research article (journal)
PD-1 checkpoint blockade in patients with relapsed AML after allogeneic stem cell transplantation Albring J., Inselmann S., Sauer T., Schliemann C., Altvater B., Kailayangiri S., Rössig C., Hartmann W., Knorrenschild J., Sohlbach K., Groth C., Lohoff M., Neubauer A., Berdel W., Burchert A., Stelljes M. (2017) In: Bone Marrow Transplantation, 52(2) Type of Publication: Research article (journal)
FUS–DDIT3 fusion protein-driven IGF-IR signaling is a therapeutic target in myxoid liposarcoma Trautmann M., Menzel J., Bertling C., Cyra M., Isfort I., Steinestel K., Elges S., Grünewald I., Altvater B., Rossig C., Fröhling S., Hafner S., Simmet T., Åman P., Wardelmann E., Huss S., Hartmann W. (2017) In: Clinical Cancer Research, 23(20) Type of Publication: Research article (journal)
Control of multidrug-resistant pseudomonas aeruginosa in allogeneic hematopoietic stem cell transplant recipients by a novel bundle including remodeling of sanitary and water… Kossow A., Kampmeier S., Willems S., Berdel W., Groll A., Burckhardt B., Rossig C., Groth C., Idelevich E., Kipp F., Mellmann A., Stelljes M. (2017) In: Clinical Infectious Diseases, 65(6) Type of Publication: Research article (journal)
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-G Kailayangiri S., Altvater B., Spurny C., Jamitzky S., Schelhaas S., Jacobs A., Wiek C., Roellecke K., Hanenberg H., Hartmann W., Wiendl H., Pankratz S., Meltzer J., Farwick N., Greune L., Fluegge M., Rossig C. (2016) In: OncoImmunology, null(null) Type of Publication: Research article (journal)
Adoptive Therapy of Ewing Sarcoma with GD2 Antigen-Specific Car-Engineered NK Cells Induces Upregulation of Immune-Inhibitory HLA-G Rossig C, Kailayangiri S, Altvater B, Spurny C, Jamitzky S, Schelhaas S, Wiek C, Hanenberg H, Hartmann W, Wiendl H, Meltzer J, Farwick N, Greune L (2016) In: Pediatric Blood and Cancer, 63(3) Type of Publication: Research article (journal)
IMPACT OF GENTAMICIN USE ON CISPLATIN-INDUCED HEARING LOSS IN PATIENTS WITH OSTEOSARCOMA Zehnhoff-Dinnesen AA, Richter K, Parfitt R, Deuster D, Roessig C, Lanvers-Kaminsky C (2015) In: Pediatric Blood and Cancer, 62(4) Type of Publication: Research article (journal)